Global Cytomegalovirus (CMV) Therapeutics Market to 2023: Market will Register a CAGR of Nearly 5% - Key Vendors are AstraZeneca, Bausch Health, F. Hoffmann-La Roche, Gilead Sciences, & Merck & Co
In: PR Newswire, 2019-04-30
Zeitungsartikel
Zugriff:
Titel: |
Global Cytomegalovirus (CMV) Therapeutics Market to 2023: Market will Register a CAGR of Nearly 5% - Key Vendors are AstraZeneca, Bausch Health, F. Hoffmann-La Roche, Gilead Sciences, & Merck & Co
|
---|---|
Zeitschrift: | PR Newswire, 2019-04-30 |
Veröffentlichung: | 2019 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|